Literature DB >> 9431971

Premarket evaluation of a commercial glycoprotein G-based enzyme immunoassay for herpes simplex virus type-specific antibodies.

R L Ashley1, L Wu, J W Pickering, M C Tu, L Schnorenberg.   

Abstract

A new commercial glycoprotein G-based enzyme immunoassay (gG-EIA) was compared with Western blotting (WB) for detection of herpes simplex virus type 1 (HSV-1) or HSV-2 type-specific antibodies in 193 serum samples. Sensitivity for HSV-1 was 95%; specificity was 96%. Sensitivity for HSV-2 was 98%; specificity was 97%. Twelve of 13 serum samples with equivocal gG-EIA results were serotyped by WB.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9431971      PMCID： PMC124858     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  19 in total

1.  Genital herpes in a primary care clinic. Demographic and sexual correlates of herpes simplex type 2 infections.

Authors:  A Wald; L Koutsky; R L Ashley; L Corey
Journal:  Sex Transm Dis       Date:  1997-03       Impact factor: 2.830

2.  Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type.

Authors:  W E Lafferty; R W Coombs; J Benedetti; C Critchlow; L Corey
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245

3.  Asymptomatic shedding and subsequent transmission of genital herpes simplex virus.

Authors:  S E Barton; J M Davis; V W Moss; A S Tyms; P E Munday
Journal:  Genitourin Med       Date:  1987-04

4.  Patient attitudes to type specific serological tests in the diagnosis of genital herpes.

Authors:  I Fairley; E F Monteiro
Journal:  Genitourin Med       Date:  1997-08

5.  The acquisition of herpes simplex virus during pregnancy.

Authors:  Z A Brown; S Selke; J Zeh; J Kopelman; A Maslow; R L Ashley; D H Watts; S Berry; M Herd; L Corey
Journal:  N Engl J Med       Date:  1997-08-21       Impact factor: 91.245

6.  A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States.

Authors:  R E Johnson; A J Nahmias; L S Magder; F K Lee; C A Brooks; C B Snowden
Journal:  N Engl J Med       Date:  1989-07-06       Impact factor: 91.245

7.  Development of clinically recognizable genital lesions among women previously identified as having "asymptomatic" herpes simplex virus type 2 infection.

Authors:  A Langenberg; J Benedetti; J Jenkins; R Ashley; C Winter; L Corey
Journal:  Ann Intern Med       Date:  1989-06-01       Impact factor: 25.391

8.  Virologic characteristics of subclinical and symptomatic genital herpes infections.

Authors:  A Wald; J Zeh; S Selke; R L Ashley; L Corey
Journal:  N Engl J Med       Date:  1995-09-21       Impact factor: 91.245

9.  Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir.

Authors:  A Wald; J Zeh; G Barnum; L G Davis; L Corey
Journal:  Ann Intern Med       Date:  1996-01-01       Impact factor: 25.391

10.  Herpes simplex virus type 2 antibody in patients attending antenatal or STD clinics.

Authors:  A L Cunningham; F K Lee; D W Ho; P R Field; C L Law; D R Packham; I D McCrossin; E Sjögren-Jansson; S Jeansson; A J Nahmias
Journal:  Med J Aust       Date:  1993-04-19       Impact factor: 7.738
View more
  36 in total

1.  Evaluation of an enzyme immunoassay system for measuring herpes simplex virus (HSV) type 1-specific and HSV type 2-specific IgG antibodies.

Authors:  H E Prince; C E Ernst; W R Hogrefe
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

Review 2.  Sorting out the new HSV type specific antibody tests.

Authors:  R L Ashley
Journal:  Sex Transm Infect       Date:  2001-08       Impact factor: 3.519

3.  HSV-2 specific seroprevalence among various populations in Rome, Italy. The Italian Herpes Management Forum.

Authors:  B Suligoi; M Cusan; P Santopadre; G Palù; S Catania; G Girelli; S Pala; V Vullo
Journal:  Sex Transm Infect       Date:  2000-06       Impact factor: 3.519

4.  Genital herpes, "the new paradigm".

Authors:  S Taylor; S Drake; D Pillay
Journal:  J Clin Pathol       Date:  1999-01       Impact factor: 3.411

5.  Longitudinal reliability of focus glycoprotein G-based type-specific enzyme immunoassays for detection of herpes simplex virus types 1 and 2 in women.

Authors:  Thomas L Cherpes; Rhoda L Ashley; Leslie A Meyn; Sharon L Hillier
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

6.  Herpes diagnostic tests and their use.

Authors:  Nicholas J Van Wagoner; Edward W Hook
Journal:  Curr Infect Dis Rep       Date:  2012-04       Impact factor: 3.725

7.  Genital herpes serotesting: a study of the epidemiology and patients' knowledge and attitude among STD clinic attenders in Coventry, UK.

Authors:  N Narouz; P S Allan; A H Wade; S Wagstaffe
Journal:  Sex Transm Infect       Date:  2003-02       Impact factor: 3.519

8.  Estimating the costs and benefits of screening monogamous, heterosexual couples for unrecognised infection with herpes simplex virus type 2.

Authors:  D N Fisman; E W Hook; S J Goldie
Journal:  Sex Transm Infect       Date:  2003-02       Impact factor: 3.519

9.  Performance of two commercial glycoprotein G-based enzyme immunoassays for detecting antibodies to herpes simplex viruses 1 and 2 in children and young adolescents.

Authors:  Charles T Leach; Rhoda L Ashley; Jacques Baillargeon; Hal B Jenson
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

10.  Dichotomy of glycoprotein g gene in herpes simplex virus type 1 isolates.

Authors:  Elham Rekabdar; Petra Tunbäck; Jan-Ake Liljeqvist; Magnus Lindh; Tomas Bergström
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.